Zealand Pharma
2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) NCT06926842 | Petrelintide | Phase 2 | Completed | Zealand Pharma | 221 | Aug 13, 2026 | Sep 9, 2026 |
| Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities NCT06662539 | Petrelintide | Phase 2 | Completed | Zealand Pharma | 493 | Sep 30, 2025 | Mar 23, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
